Brought to you by 
Arbutus, Spring Bank enter HBV trial collaboration
20 Apr 2021
Executive Summary
Spring Bank Pharmaceuticals Inc. and Arbutus Biopharma Corp. have entered into a trial collaboration to investigate the co-administration of Spring Bank’s SB9200 and Arbutus' AB423 for hepatitis B.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Trial Collaborations
- R&D (No Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Arbutus, Spring Bank enter HBV trial collaboration
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice